J&J sells Ortho-Clinical Diagnostics; Prana falls

Shares of Johnson & Johnson attract attention in premarket trade Monday after it agrees to sell a unit, while shares of Prana Biotechnology Ltd. were slammed after an Alzheimer’s treatment doesn’t pass a clinical trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.